Why the weight-loss drugs battle will intensify in 2026, explained in 5 charts
Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a fight for global dominance.
Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a fight for global dominance.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
